NO20062970L - 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia - Google Patents

7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia

Info

Publication number: NO20062970L
Authority: NO; Norway
Prior art keywords: chlorobenzyloxy; benzenesulfonyl; tetrahydro; methoxy; methyl
Prior art date: 2003-11-28

Application number

NO20062970A

Other languages

English (en)

Norwegian (no)

Inventor

David Clapham

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-28

Filing date

2006-06-26

Publication date

2006-08-21

2006-06-26 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2006-08-21 Publication of NO20062970L publication Critical patent/NO20062970L/no

Links

VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 title 1
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 title 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 title 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1
HIBWHHQXUSKNOV-UHFFFAOYSA-N 7-[4-[(4-chlorophenyl)methoxy]phenyl]sulfonyl-8-methoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical class COC1=CC=2CCN(C)CCC=2C=C1S(=O)(=O)C(C=C1)=CC=C1OCC1=CC=C(Cl)C=C1 HIBWHHQXUSKNOV-UHFFFAOYSA-N 0.000 abstract 1
239000000164 antipsychotic agent Substances 0.000 abstract 1
229940005529 antipsychotics Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)

NO20062970A 2003-11-28 2006-06-26 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia NO20062970L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0327740.7A GB0327740D0 (en)	2003-11-28	2003-11-28	Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en)	2003-11-28	2004-11-25	7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (1)

Publication Number	Publication Date
NO20062970L true NO20062970L (no)	2006-08-21

Family

ID=29798028

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062970A NO20062970L (no)	2003-11-28	2006-06-26	7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia

Country Status (18)

Country	Link
US (1)	US20070275948A1 (pt)
EP (1)	EP1687279A1 (pt)
JP (1)	JP2007512285A (pt)
KR (1)	KR20060103322A (pt)
CN (1)	CN1906170A (pt)
AR (1)	AR046719A1 (pt)
AU (1)	AU2004293179A1 (pt)
BR (1)	BRPI0417029A (pt)
CA (1)	CA2547444A1 (pt)
GB (1)	GB0327740D0 (pt)
IL (1)	IL175663A0 (pt)
IS (1)	IS8500A (pt)
MA (1)	MA28177A1 (pt)
NO (1)	NO20062970L (pt)
RU (1)	RU2006122959A (pt)
TW (1)	TW200528433A (pt)
WO (1)	WO2005051916A1 (pt)
ZA (1)	ZA200603781B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0510599D0 (en) *	2005-05-24	2005-06-29	Glaxo Group Ltd	Novel compounds
GB0603087D0 (en) *	2006-02-15	2006-03-29	Glaxo Group Ltd	Novel use
NZ586675A (en) *	2008-01-08	2012-04-27	Merck Sharp & Dohme	Pharmaceutically acceptable salts of 2-{ 4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
CA2970502A1 (en) *	2014-12-12	2016-06-16	The Schepens Eye Research Institute, Inc.	Gdnf induction for the treatment of retinal disorders
JP7185633B2 (ja)	2017-02-17	2022-12-07	トレベナ・インコーポレイテッド	７員アザ複素環を含有するデルタ－オピオイド受容体調節化合物、その使用方法及び製造方法
US20210347758A1 (en)	2018-10-03	2021-11-11	Tesaro, Inc.	Crystalline Forms of Niraparib Freebase
EP4236939A4 (en) *	2020-10-27	2024-08-07	Trevena, Inc.	Crystalline and amorphous forms of a delta-opioid modulator
CN115998724B (zh) *	2023-03-28	2023-06-16	中国人民解放军军事科学院军事医学研究院	布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005518414A (ja) *	2001-12-21	2005-06-23	スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー	ドーパミン受容体のモジュレーターとしての７−スルホニル−３−ベンゾアゼピン誘導体およびｃｎｓ障害の治療のためのその使用
AU2003215558A1 (en) *	2002-02-13	2003-09-04	Glaxo Group Limited	Benzenesulfonamide derivatives as antipsychotic agents
MY133587A (en) *	2002-05-29	2007-11-30	Glaxo Group Ltd	Aromatic sulfones and their medical use

2003
- 2003-11-28 GB GBGB0327740.7A patent/GB0327740D0/en not_active Ceased
2004
- 2004-11-25 EP EP04819223A patent/EP1687279A1/en not_active Withdrawn
- 2004-11-25 US US10/580,640 patent/US20070275948A1/en not_active Abandoned
- 2004-11-25 AU AU2004293179A patent/AU2004293179A1/en not_active Abandoned
- 2004-11-25 JP JP2006540389A patent/JP2007512285A/ja active Pending
- 2004-11-25 KR KR1020067010371A patent/KR20060103322A/ko not_active Withdrawn
- 2004-11-25 RU RU2006122959/04A patent/RU2006122959A/ru not_active Application Discontinuation
- 2004-11-25 WO PCT/EP2004/013416 patent/WO2005051916A1/en not_active Ceased
- 2004-11-25 CA CA002547444A patent/CA2547444A1/en not_active Abandoned
- 2004-11-25 CN CNA2004800410778A patent/CN1906170A/zh active Pending
- 2004-11-25 BR BRPI0417029-6A patent/BRPI0417029A/pt not_active IP Right Cessation
- 2004-11-26 AR ARP040104393A patent/AR046719A1/es not_active Application Discontinuation
- 2004-11-26 TW TW093136389A patent/TW200528433A/zh unknown
2006
- 2006-05-10 ZA ZA200600378A patent/ZA200603781B/xx unknown
- 2006-05-16 IL IL175663A patent/IL175663A0/en unknown
- 2006-05-24 MA MA29055A patent/MA28177A1/fr unknown
- 2006-06-08 IS IS8500A patent/IS8500A/xx unknown
- 2006-06-26 NO NO20062970A patent/NO20062970L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1906170A (zh)	2007-01-31
CA2547444A1 (en)	2005-06-09
AR046719A1 (es)	2005-12-21
KR20060103322A (ko)	2006-09-28
US20070275948A1 (en)	2007-11-29
WO2005051916A1 (en)	2005-06-09
EP1687279A1 (en)	2006-08-09
TW200528433A (en)	2005-09-01
ZA200603781B (en)	2007-09-26
MA28177A1 (fr)	2006-09-01
AU2004293179A1 (en)	2005-06-09
GB0327740D0 (en)	2003-12-31
BRPI0417029A (pt)	2007-02-06
RU2006122959A (ru)	2008-01-10
IS8500A (is)	2006-06-08
JP2007512285A (ja)	2007-05-17
IL175663A0 (en)	2006-09-05

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20050668L (no)	2005-04-05	7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater
GEP20084357B (en)	2008-04-29	Pyrimidine derivatives for the treatment of abnormal cell growth
NO20073059L (no)	2007-07-19	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MY132106A (en)	2007-09-28	New pyridazin-3(2h)-one derivatives
PA8548701A1 (es)	2003-02-14	Azaindoles
MXPA03007140A (es)	2004-05-24	Derivados de carbolina.
MY130803A (en)	2007-07-31	New quinuclidine amide derivatives
NO20025821L (no)	2003-02-04	2-aminokarbonyl-9H-purinderivater
DE69931617D1 (de)	2006-07-06	Taxan-mikroemulsionen
NO20032905L (no)	2003-06-24	Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister
EP1472230A4 (en)	2005-07-06	ANSAMYCINS WITH IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES
BR0016543A (pt)	2002-09-17	Novos derivados de piperidina e piperazina
DE60230127D1 (de)	2009-01-15	Inhibitoren von integrin alpha-v-beta-6
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser
ECSP055701A (es)	2005-05-30	Nuevos derivados de pirimidinamida y el uso de los mismos
SE9903544D0 (sv)	1999-10-01	Novel compounds
DK0734383T3 (da)	2002-10-14	Cykliske amidderivater som neurokinin-A-antagonister
WO2004100865A3 (en)	2005-01-20	New benzimidazole derivatives
ATE386725T1 (de)	2008-03-15	Heterocyclylverbindungen
NO20061839L (no)	2006-06-26	Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
MXPA05007609A (es)	2005-09-30	Antagonista de un receptor sensible al calcio.
NO20054763L (no)	2006-01-16	Salter av clopidogrel og fremgangsmate for fremstilling derav
MXPA03010761A (es)	2004-03-02	Combinaciones farmaceuticas.
WO2003031407A3 (en)	2003-11-13	β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
NO20060020L (no)	2006-03-03	3-fluorpiperidiner som NMDA/NR2B-antagonister